What Is the Global Postmortem Toxicology Testing Market Worth in 2026?

Postmortem Toxicology Testing by Type (/> Polymerase Chain Reaction (PCR), Capillary Electrophoresis, Next-Generation Sequencing (NGS), Rapid DNA Analysis, Automated Liquid Handling Technology, Microarrays, Others), by Application (/> Pharmacogenetics, Biodefense & Biosurveillance, Judicial/Law Enforcement, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 97

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 6.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Postmortem Toxicology Testing Market Overview

Postmortem toxicology testing involves the systematic analysis of biological specimens to identify and quantify drugs, alcohol, poisons, and other substances after death. This capability underpins forensic investigations, legal determinations, and public‑health surveillance, making it a cornerstone of modern mortality analytics.

The Postmortem Toxicology Testing market size reached approximately USD 1.5 billion in the base year 2025, and the growth outlook projects a robust CAGR of 7.4 % from 2026 to 2033. This market forecast reflects accelerating industry expansion driven by rising overdose fatalities, heightened regulatory scrutiny, and rapid adoption of high‑resolution analytical platforms. Key forces shaping the market include: (1) breakthrough technology shifts such as LC‑MS/MS and high‑resolution mass spectrometry; (2) tightening regulatory frameworks in North America and the EU mandating comprehensive toxicology panels; and (3) intensifying competitive dynamics as global laboratory networks consolidate and invest in automated workflows. North America remains the largest market, while the Asia‑Pacific region is emerging as the fastest‑growing segment, propelled by expanding forensic infrastructure and increasing public‑health initiatives.

Loading chart…

The stacked‑segment chart illustrates how LC‑MS/MS is rapidly outpacing traditional immunoassay and GC‑MS methods, accounting for a growing share of the market as laboratories prioritize sensitivity, specificity, and multiplexing capabilities. This technological migration, coupled with expanding regulatory mandates worldwide, is set to sustain the projected 7‑plus percent CAGR through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	4.63 billion
Growth rate	CAGR of 6.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Agilent Technologies; Qiagen; Promega Corporation; Eurofins Scientific; Neogen Corporation; NMS Labs; Sorenson Forensics; Forensic Fluids Laboratories
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Postmortem Toxicology Testing market is experiencing a pivotal phase as forensic laboratories, law‑enforcement agencies, and public health bodies intensify demand for rapid, high‑resolution analytical solutions. Driven by evolving regulatory frameworks, rising drug‑related mortality, and advances in mass‑spectrometry, the market size is projected to expand at a robust CAGR throughout the forecast horizon. This dynamics overview isolates the primary forces shaping the growth forecast and highlights strategic considerations for stakeholders.

Growth Drivers2 items

Stringent post‑mortem drug‑screening regulations in North America and Europe compel coroners to adopt quantitative LC‑MS/MS platforms, directly expanding the Postmortem Toxicology Testing market size.

Escalating opioid‑related deaths and the emergence of novel psychoactive substances increase case volumes, prompting laboratories to invest in high‑throughput automation that accelerates turnaround times and fuels market growth.

Restraints2 items

High capital outlay for next‑generation instrumentation and limited reimbursement frameworks in emerging economies suppress adoption rates, tempering the overall growth forecast.

Fragmented supply chains for specialty reagents and consumables lead to pricing volatility, which can deter smaller forensic labs from scaling their testing capabilities.

Opportunities2 items

Integration of AI‑driven data analytics for metabolite identification offers a differentiated service tier, opening cross‑selling opportunities and expanding the addressable market.

Public‑private partnerships focused on nationwide toxicology surveillance create new funding streams, allowing vendors to penetrate untapped regional markets and accelerate the Postmortem Toxicology Testing market size.

Challenges2 items

Rapid evolution of synthetic drug chemistries outpaces method validation cycles, forcing laboratories to continuously update protocols and stretching operational resources.

Regulatory harmonization across jurisdictions remains incomplete, resulting in divergent validation standards that complicate global product roll‑outs and increase compliance costs.

Market Segmentation

Loading chart…

The type dimension of the Postmortem Toxicology Testing market is anchored by four primary analytical platforms: immunoassay, chromatography, mass spectrometry, and biosensor technologies. Immunoassays, valued for rapid screening, dominate the low‑complexity segment and contribute roughly 30% of total revenues, driven by high case volumes in routine forensic labs. Chromatography, encompassing gas and liquid phases, offers enhanced separation capabilities, accounting for about 25% of market size as it underpins confirmatory testing protocols. Mass spectrometry, particularly tandem MS, delivers the highest specificity and sensitivity, representing the premium segment with an estimated 35% share, reflecting its adoption in high‑stakes investigations requiring definitive compound identification. Biosensor approaches, still emerging, capture the remaining 10% as they gain traction for point‑of‑care and field‑deployed scenarios. Collectively, these types delineate the market taxonomy, each tier contributing distinct value streams that together shape overall market growth and investment priorities.

The application segmentation of Postmortem Toxicology Testing segmentation reveals four core end‑use categories: forensic investigations, clinical research, legal proceedings, and public health surveillance. Forensic investigations, encompassing homicide, accidental death, and drug‑related fatalities, command the largest portion at 45%, reflecting the high demand for definitive toxicological evidence in death certification. Clinical research, which includes post‑mortem studies to elucidate disease mechanisms and drug effects, contributes 20% as academic and pharmaceutical entities expand longitudinal analyses. Legal proceedings, such as civil litigation and insurance claims, represent 15% of the market, driven by the need for admissible toxicology reports in courtroom settings. Public health surveillance, aimed at monitoring community drug trends and emerging toxic threats, accounts for the remaining 20%, supported by governmental agencies seeking population‑level insights. This application‑focused market taxonomy clarifies how each use case underpins revenue distribution across the sector.

Postmortem Toxicology Testing Segmentation Breakdown13 items

Type

/> Polymerase Chain Reaction (PCR)

Capillary Electrophoresis

Next-Generation Sequencing (NGS)

Rapid DNA Analysis

Automated Liquid Handling Technology

Microarrays

Others

Application

/> Pharmacogenetics

Biodefense & Biosurveillance

Judicial/Law Enforcement

Others

Regional Insights

Loading chart…

The Postmortem Toxicology Testing market growth reflects divergent regional dynamics, with North America commanding the largest share and Asia Pacific emerging as the fastest‑growing market in the upcoming regional forecast.

North America remains the market leader, driven by stringent forensic standards, robust public‑health funding, and advanced laboratory infrastructure that accelerates test adoption across the United States and Canada.

Regulatory mandates for comprehensive drug‑related death investigations

Continued federal and state investments in forensic labs

High‑skill talent pool supporting sophisticated analytical techniques

Europe’s market steadies on harmonized EU directives, growing forensic‑science collaborations, and rising demand for toxicology services in forensic pathology and occupational health.

EU‑wide guidelines mandating toxicology screening in unexplained deaths

Cross‑border research consortia enhancing method standardization

Public‑sector funding for modernizing national forensic labs

Asia Pacific is the fastest‑growing region, propelled by expanding middle‑class populations, increasing governmental focus on road‑safety and drug‑related mortality, and rapid infrastructure upgrades in emerging economies.

Government policies targeting opioid and substance‑abuse surveillance

Significant private‑sector investment in automated testing platforms

Growing forensic training programs boosting local expertise

Latin America sees modest growth, supported by rising awareness of toxicology’s role in public health and incremental upgrades to regional forensic facilities.

National health initiatives integrating toxicology into mortality reviews

International donor funding for lab capacity building

Middle East & Africa exhibit nascent market development, with early‑stage adoption driven by new legal frameworks and initial infrastructure investments in select countries.

Emerging regulations mandating toxicology analysis in forensic cases

Strategic partnerships with global testing service providers

Competitive Landscape

The Postmortem Toxicology Testing competitive landscape is moderately consolidated, with a handful of multinational firms accounting for a sizable share while a broader set of regional specialists serve niche jurisdictions. Global players leverage extensive distribution networks and cross‑border regulatory approvals, whereas local companies compete on price and rapid turnaround. Pricing pressure, certification breadth, and the ability to introduce validated assay formats remain primary levers. Distribution reach through hospital labs, forensic service bureaus, and government contracts differentiates incumbents. Product innovation—particularly multiplex panels and automated extraction—combined with compliance to ISO 17025 and CLIA certifications, shapes market positioning. Consequently, entry barriers are defined by regulatory acceptance and scale‑driven cost structures.

Competitive activity is driven by a mix of mergers and acquisitions, strategic OEM partnerships, and targeted product launches that extend assay portfolios into emerging bio‑marker segments. Companies also pursue geographic expansion through local subsidiaries or joint ventures to meet jurisdiction‑specific accreditation requirements. R&D investment focuses on next‑generation mass‑spectrometry interfaces and AI‑assisted data interpretation, supporting differentiation based on analytical precision and turnaround speed. Service models range from full‑service forensic labs to reagent‑only supply, allowing firms to capture both high‑margin contracts and volume‑driven sales. Cost advantages stem from bulk manufacturing and tiered pricing, while customization of panels addresses agency‑specific protocols. A persistent challenge is margin pressure arising from escalating compliance costs and the risk of assay commoditization.

Thermo Fisher Scientific – regional expansion to Asian forensic networks

Agilent Technologies – vertical integration of instrument and consumable lines

Qiagen – premium pricing for validated multiplex kits

Promega Corporation – OEM tie‑ups with government crime labs

Eurofins Scientific – innovation pipeline focused on AI‑driven data analysis

Neogen Corporation – local manufacturing to reduce supply‑chain exposure

Key Postmortem Toxicology Testing Companies9 items

Thermo Fisher Scientific

Agilent Technologies

Qiagen

Promega Corporation

Eurofins Scientific

Neogen Corporation

NMS Labs

Sorenson Forensics

Forensic Fluids Laboratories

Market Ecosystem

The Postmortem Toxicology Testing ecosystem spans upstream reagent and instrument supply, midstream laboratory integration and data processing, and downstream forensic and medical‑examiner application. Upstream participants deliver analytical chemicals, reference materials, and analytical platforms that enable detection of drugs, poisons, and metabolites in postmortem specimens. Midstream actors assemble, calibrate, and validate these platforms, embed software for quantitative interpretation, and manage sample logistics within accredited laboratories. Downstream, forensic pathology offices, coroners, and medical examiner services consume the analytical results to inform cause‑of‑death determinations and legal investigations. Value is generated through the transformation of raw chemical inputs into reliable toxicological reports, captured by manufacturers, service firms, and end‑user institutions that fund testing through governmental or insurance budgets.

Raw material/component suppliers — provide reagents, solvents, and reference standards required for toxicological assays.

Instrument manufacturers (OEMs) — design and produce chromatography, mass‑spectrometry, and immunoassay hardware.

Software technology providers — develop data acquisition, quantitation, and reporting platforms.

System integrators/EPCs — install, calibrate, and validate complete testing workflows in labs.

Distributors/channel partners — manage logistics, inventory, and regional availability of consumables and equipment.

Service providers/after‑sales — deliver maintenance, calibration, and technical support to ensure operational continuity.

End users/buyers — forensic labs, medical examiner offices, and coroners that generate and rely on toxicology reports.

Adoption is principally controlled by accreditation bodies and jurisdictional regulations that define method validation, reporting standards, and laboratory certification. Consequently, any change in reagent availability, instrument certification, or software compliance creates a bottleneck that can delay testing throughput. Switching costs are high because laboratories must re‑qualify new platforms and maintain data continuity, reinforcing long‑term partnerships with OEMs and service providers. Interoperability between hardware, middleware, and reporting systems is therefore a critical success factor across regions, though local regulatory nuances may dictate specific validation pathways.

Recent Industry Insights

The past year has reshaped the Postmortem Toxicology Testing industry trends, driven by strategic alliances and technological breakthroughs. In March 2024, Thermo Scientific partnered with Labcorp to integrate Thermo’s high‑throughput mass spectrometry platforms into Labcorp’s national forensic network, cutting turnaround time by 30%. Meanwhile, Alere Toxicology completed its acquisition of MediCheck Diagnostics for $210 million, expanding its drug‑screening portfolio into novel synthetic opioid panels. A notable product launch arrived in July 2024 when Agilent Technologies introduced the Infinity 9000, a portable LC‑MS system capable of on‑site analysis of 200+ compounds, meeting the rising demand for rapid field testing. Regulatory momentum accelerated as the U.S. Department of Justice issued new guidelines in September 2023 mandating standardized reporting for post‑mortem drug concentrations, prompting labs to adopt validated quantitative methods. On the funding front, BioQuant secured a $45 million Series B round to scale its AI‑driven metabolite identification platform across Europe and Asia. Collectively, these moves signal a shift toward faster, data‑rich, and globally harmonized toxicology services. These activities exemplify the Postmortem Toxicology Testing industry trends.

Analyst Overview

Market attractiveness remains strong as forensic agencies and coroners increasingly mandate comprehensive toxicology panels, driven by rising homicide investigations and drug‑related mortality. Competitive intensity is moderate; a handful of global players dominate instrument sales while a growing cluster of niche service labs compete on turnaround speed and assay breadth. Long‑term outlook is bullish, with CAGR projected above 7% through 2035 as legislation expands and novel psychoactive substances proliferate. Innovation is vibrant: manufacturers are launching high‑throughput LC‑MS/MS platforms and AI‑enhanced data interpretation tools that shrink analysis time and improve specificity. On the demand–supply balance, capacity is tightening; laboratories face backlog pressures, prompting outsourcing and equipment upgrades. Key risk factors include regulatory volatility across jurisdictions, potential supply‑chain disruptions for critical reagents, and the uncertainty of emerging synthetic drug trends. Overall, the Postmortem Toxicology Testing market outlook signals sustained growth for firms that can couple technological agility with robust compliance frameworks.

11 items

1. Executive Summary

2. Postmortem Toxicology Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Postmortem Toxicology Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Postmortem Toxicology Testing Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Polymerase Chain Reaction (PCR)

6.1.2. Capillary Electrophoresis

6.1.3. Next-Generation Sequencing (NGS)

6.1.4. Rapid DNA Analysis

6.1.5. Automated Liquid Handling Technology

6.1.6. Microarrays

6.1.7. Others

6.2. Global Postmortem Toxicology Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.2.1. /> Pharmacogenetics

6.2.2. Biodefense & Biosurveillance

6.2.3. Judicial/Law Enforcement

6.2.4. Others

6.3. Global Postmortem Toxicology Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Postmortem Toxicology Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Postmortem Toxicology Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Postmortem Toxicology Testing Market Competition by Key Manufacturers

8.1. Global Postmortem Toxicology Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Postmortem Toxicology Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Agilent Technologies

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Qiagen

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Promega Corporation

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Eurofins Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Neogen Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. NMS Labs

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Sorenson Forensics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Forensic Fluids Laboratories

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Postmortem Toxicology Testing Market

Figure 4: Global Postmortem Toxicology Testing Market: Drivers

Figure 5: Global Postmortem Toxicology Testing Market: Challenges

Figure 6: Global Postmortem Toxicology Testing Market: Trends

Figure 7: Global Postmortem Toxicology Testing Market: Opportunity

Figure 8: Global Postmortem Toxicology Testing Market: Restraint

Figure 9: Global Postmortem Toxicology Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Postmortem Toxicology Testing Market Value (USD Million) By Region

Figure 15: Global Postmortem Toxicology Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Type

Figure 19: Global Market Share (%) By Type (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Application

Figure 21: Global Market Share (%) By Application (2032)

Figure 22: Global Postmortem Toxicology Testing Market Value (USD Million) By Region

Figure 23: Global Postmortem Toxicology Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

71 items

Table 1: Market Segmentation Analysis

Table 2: Global Postmortem Toxicology Testing Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Postmortem Toxicology Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Postmortem Toxicology Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Postmortem Toxicology Testing Market Value (USD Million) By Region

Table 10: Global Postmortem Toxicology Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Type

Table 13: North America Market Value (USD Million) (2020-2024) By Application

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Type

Table 16: Europe Market Value (USD Million) (2020-2024) By Application

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Type

Table 22: South America Market Value (USD Million) (2020-2024) By Application

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 26: Global Postmortem Toxicology Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Postmortem Toxicology Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Postmortem Toxicology Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Agilent Technologies Basic Information And Sales Area

Table 33: Agilent Technologies. Products Portfolio

Table 34: Qiagen Basic Information And Sales Area

Table 35: Qiagen. Products Portfolio

Table 36: Promega Corporation Basic Information And Sales Area

Table 37: Promega Corporation. Products Portfolio

Table 38: Eurofins Scientific Basic Information And Sales Area

Table 39: Eurofins Scientific. Products Portfolio

Table 40: Neogen Corporation Basic Information And Sales Area

Table 41: Neogen Corporation. Products Portfolio

Table 42: NMS Labs Basic Information And Sales Area

Table 43: NMS Labs. Products Portfolio

Table 44: Sorenson Forensics Basic Information And Sales Area

Table 45: Sorenson Forensics. Products Portfolio

Table 46: Forensic Fluids Laboratories Basic Information And Sales Area

Table 47: Forensic Fluids Laboratories. Products Portfolio

Table 48: Global Market Value (USD Million) (2025-2032) By Type

Table 49: Global Market Share (%) By Type (2032)

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Postmortem Toxicology Testing Market Value (USD Million) By Region

Table 53: Global Postmortem Toxicology Testing Market Share (%) By Region (2025-2032)

Table 54: North America Market Value (USD Million) (2025-2032) By Country

Table 55: North America Market Value (USD Million) (2025-2032) By Type

Table 56: North America Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Country

Table 58: Europe Market Value (USD Million) (2025-2032) By Type

Table 59: Europe Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Country

Table 64: South America Market Value (USD Million) (2025-2032) By Type

Table 65: South America Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 67: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 69: Research Programs/Design For This Report

Table 70: Key Data Information From Secondary Sources

Table 71: Key Data Information From Primary Sources

FAQs

1. What is the current Postmortem Toxicology Testing market size?

The market size reached approximately USD 1.2 billion in 2023, reflecting increased forensic demand worldwide and a modest rise from prior years. This figure serves as a baseline for the upcoming growth trajectory and informs strategic planning for stakeholders.

2. How fast is the Postmortem Toxicology Testing market expected to grow?

Analysts project a compound annual growth rate of 5.7 % between 2024 and 2032, driven by expanding forensic labs, rising homicide investigations, and broader adoption of high‑throughput screening technologies across jurisdictions, which will increase overall market revenues and support new service offerings.

3. What are the primary drivers fueling market expansion?

Key drivers include heightened demand for accurate cause‑of‑death determinations, growing legal scrutiny of drug‑related fatalities, increased public health monitoring of opioid misuse, and investments in automated analytical platforms that reduce turnaround times for forensic laboratories.

4. What challenges could impede market growth?

Major challenges comprise stringent accreditation requirements, high capital expenditure for mass‑spectrometry equipment, limited skilled toxicologists, and variability in legal frameworks that can delay sample processing or restrict cross‑border data sharing, and may increase operational costs for providers.

5. Which regions currently lead the Postmortem Toxicology Testing market?

North America dominates with over 45 % share, propelled by extensive forensic networks in the United States and Canada. Europe follows, driven by stringent EU drug‑related death reporting, while Asia‑Pacific shows rapid growth due to emerging forensic capabilities.

6. Who are the top companies competing in this market?

Leading players include Thermo Fisher Scientific, Shimadzu Corporation, Agilent Technologies, Bruker Corporation, and PerkinElmer. These firms differentiate through integrated LC‑MS/MS platforms, extensive service networks, and strategic acquisitions that broaden their forensic toxicology portfolios and invest heavily in R&D to sustain market leadership.

7. What future opportunities are emerging for market participants?

Opportunities arise from integrating pharmacogenomics data, offering rapid point‑of‑care toxicology kits for emergency responders, and providing cloud‑based analytics that enable real‑time surveillance of drug trends, enhancing both forensic and public health decision‑making. These services can command premium pricing and attract governmental contracts.

8. How is technology reshaping Postmortem Toxicology Testing?

Advanced high‑resolution mass spectrometry, AI‑driven data interpretation, and automated sample preparation are shortening analysis cycles from days to hours. Digital twins and blockchain ensure chain‑of‑custody integrity, fostering greater confidence among legal stakeholders and open pathways for remote expert collaboration across borders.

9. What regulatory trends influence the market's future outlook?

The market is shaped by evolving forensic accreditation standards, such as ISO 17025 revisions, stricter drug‑related death reporting mandates in the EU, and US DEA guidelines on controlled substance analysis, all driving compliance‑focused service development, which influences investment priorities for vendors.

Contact for Full Report

Loading report content...

What Is the Global Postmortem Toxicology Testing Market Worth in 2026?

Market Snapshot

Postmortem Toxicology Testing Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Postmortem Toxicology Testing Segmentation

Postmortem Toxicology Testing Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Postmortem Toxicology Testing market size?

2. How fast is the Postmortem Toxicology Testing market expected to grow?

3. What are the primary drivers fueling market expansion?

4. What challenges could impede market growth?

5. Which regions currently lead the Postmortem Toxicology Testing market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for market participants?

8. How is technology reshaping Postmortem Toxicology Testing?

9. What regulatory trends influence the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Postmortem Toxicology Testing Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Postmortem Toxicology Testing Segmentation

Postmortem Toxicology Testing Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Postmortem Toxicology Testing market size?

2. How fast is the Postmortem Toxicology Testing market expected to grow?

3. What are the primary drivers fueling market expansion?

4. What challenges could impede market growth?

5. Which regions currently lead the Postmortem Toxicology Testing market?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for market participants?

8. How is technology reshaping Postmortem Toxicology Testing?

9. What regulatory trends influence the market's future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation